- 🇸🇦 Saudi Stock Market
- 🇺🇸 USA Stock Market
Biogen Inc. is a biotechnology company that develops and delivers treatments for neurological and neurodegenerative diseases. Its key products include therapies for multiple sclerosis, spinal muscular atrophy, ALS, Friedreich’s Ataxia, and several biosimilars for conditions like arthritis and cancer. Biogen also collaborates with major partners such as Eisai, Genentech, Ionis, and Sage Therapeutics to develop new drugs in areas like Alzheimer’s, Parkinson’s, and other brain disorders. Founded in 1978, the company is headquartered in Cambridge, Massachusetts.
| Metric | Q3 2025 | Q2 2025 | Change (QoQ) | Q3 2024 | Change (YoY) |
|---|---|---|---|---|---|
| Total Revenue | $2.535B | $2.646B | -4.2% | $2.466B | +2.8% |
| GAAP Diluted EPS | $3.17 | $4.33 | -26.8% | $2.66 | +19.2% |
| Non-GAAP Diluted EPS | $4.81 | $5.47 | -12.1% | $4.08 | +17.9% |
| Free Cash Flow | $1.226B | $0.134B | +814.9% | $0.901B | +36.1% |
| Launch Products Revenue | $257M | $291M | -11.7% | $153.8M | +67.0% |
| MS Franchise Revenue | $1.062B | $1.107B | -4.1% | $1.052B | +0.9% |
BIIB — NASDAQ —
| Indicator | Value | Zone |
|---|---|---|
| RSI-14 | 72.14 | Overbought |
| CCI-14 | 75.73 | Neutral |
| ROC | 12.98 | Positive |
| Stochastic %K | 82.64 | Neutral |
| William %R | -18.07 | Overbought |
| EMA | Value | Stock Position |
|---|---|---|
| 5 EMA | 178.92 | Above |
| 10 EMA | 175.75 | Above |
| 20 EMA | 169.41 | Above |
| 50 EMA | 158.21 | Above |
| 100 EMA | 149.65 | Above |
| 200 EMA | 150.01 | Above |
Based on our swing stock trading tips in USA stocks, Biogen stock price target will be USD 188 - USD 190 in the next 12-14 trading sessions.
Arijit Banerjee CMT CFTe is a seasoned expert in the financial industry, boasting decades of experience in trading, investment, and wealth management. As the founder and chief strategist of Naranj Capital, he’s built a reputation for providing insightful research analysis to guide investment decisions.
Arijit’s credentials are impressive, holding both the Chartered Market Technician (CMT) and Certified Financial Technician (CFTe) designations. These certifications demonstrate his expertise in technical analysis and financial markets.
Through Naranj Capital, Arijit shares his market insights and research analysis, offering actionable advice for investors. His work is featured on platforms like TradingView, where he publishes detailed analysis and recommendations.
If you’re interested in learning more about Arijit’s work or Naranj Capital’s services, you can reach out to them directly through their website
